Mohamed Hassanein
YOU?
Author Swipe
View article: Outcomes of People with Type 2 Diabetes using Sulfonylureas versus Other Non-Insulin Antidiabetic Agents during Ramadan: The Diabetes and Ramadan (DaR) Global Surveys
Outcomes of People with Type 2 Diabetes using Sulfonylureas versus Other Non-Insulin Antidiabetic Agents during Ramadan: The Diabetes and Ramadan (DaR) Global Surveys Open
There is an increasing need to investigate fasting outcomes for Muslims with type 2 diabetes (T2D) who choose to fast during Ramadan. Although sulfonylureas (SUs) are widely used in T2D, concerns persist regarding their risk of hypoglycemi…
View article: Use of Fixed Ratio Combinations to Improve Glycemic Control in Individuals with Type 2 Diabetes: Experts’ Opinion from the Gulf Region
Use of Fixed Ratio Combinations to Improve Glycemic Control in Individuals with Type 2 Diabetes: Experts’ Opinion from the Gulf Region Open
Sequential addition of oral glucose-lowering therapies, insulin or incretin-based therapy is often required to attain optimal glycemic control and reduce the risk of diabetes-associated complications. Despite advances in treatment, a large…
View article: The 2026 Update of the IDF-DAR Risk Calculator for Fasting in People with Diabetes
The 2026 Update of the IDF-DAR Risk Calculator for Fasting in People with Diabetes Open
Risk stratification is essential for guiding individuals with diabetes during Ramadan. While the 2021 International Diabetes Federation–Diabetes and Ramadan (IDF-DAR) Risk Calculator provided a structured, evidence-based approach, recent m…
View article: Characteristics of Fasting in Ramadan in Type 2 Diabetes Patients on Empagliflozin in the DAR Global Surveys of 2020 and 2022
Characteristics of Fasting in Ramadan in Type 2 Diabetes Patients on Empagliflozin in the DAR Global Surveys of 2020 and 2022 Open
The safety of Ramadan fasting in individuals is determined by an interplay between Ramadan, patients, and medication factors. To analyze the challenges associated with Ramadan fasting among patients with diabetes treated with Empagliflozin…
View article: Impact of Albuminuria and Renal Function on Ramadan Fasting in Type 2 Diabetes
Impact of Albuminuria and Renal Function on Ramadan Fasting in Type 2 Diabetes Open
Diabetic kidney disease (DKD) is a common and serious complication, defined by albuminuria and/or reduced estimated glomerular filtration rate (eGFR). This study explored the impact of DKD and its subgroups on glycemic control and fasting …
View article: The Impact of Macrovascular Disease in People with Type 2 Diabetes on Ramadan Fasting Practices and Glycemic Outcomes: Insights from a Multinational Real-World Study
The Impact of Macrovascular Disease in People with Type 2 Diabetes on Ramadan Fasting Practices and Glycemic Outcomes: Insights from a Multinational Real-World Study Open
The International Diabetes Federation–Diabetes and Ramadan (IDF-DAR) Risk Score is widely used to guide fasting recommendations for individuals with type 2 diabetes mellitus (T2D) during the month of Ramadan. Many patients with macrovascul…
View article: Correlation between Pre-Ramadan HbA1c Levels and Fasting Outcomes in Individuals with Type 2 Diabetes: Evidence from the Global 2020–2022 DAR Survey
Correlation between Pre-Ramadan HbA1c Levels and Fasting Outcomes in Individuals with Type 2 Diabetes: Evidence from the Global 2020–2022 DAR Survey Open
Glycemic control prior to Ramadan is considered an essential determinant of fasting safety in individuals with diabetes. While the International Diabetes Federation-Diabetes and Ramadan Alliance risk calculator incorporates glycated hemogl…
View article: Ramadan Fasting in Individuals with Diabetic Retinopathy: A Retrospective Cohort Study from the Diabetes and Ramadan Global Survey
Ramadan Fasting in Individuals with Diabetic Retinopathy: A Retrospective Cohort Study from the Diabetes and Ramadan Global Survey Open
Data on the impact of diabetic retinopathy (DR) on Ramadan fasting are limited. DR is not currently considered in pre-Ramadan risk stratification. However, its association with longer diabetes duration, poor glycemic control, and insulin u…
View article: Impact of Ramadan Fasting in People with Type 1 Diabetes and Diabetic Kidney Disease: Insights from the DaR Global Survey
Impact of Ramadan Fasting in People with Type 1 Diabetes and Diabetic Kidney Disease: Insights from the DaR Global Survey Open
Despite the scarcity of data, individuals with type 1 diabetes mellitus (T1D) and diabetic kidney disease (DKD) are considered at moderate to high risk for Ramadan fasting and are individually advised against fasting. This subgroup analysi…
View article: The DAR Survey of Physicians' Use of GLP-1 Receptor Agonists and SGLT2 Inhibitors during Ramadan
The DAR Survey of Physicians' Use of GLP-1 Receptor Agonists and SGLT2 Inhibitors during Ramadan Open
While existing studies and guidelines have supported the safety of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and sodium-glucose cotransporter-2 (SGLT2) inhibitors during Ramadan, little is known about how these recommendations …
View article: Effect of Different Insulin Regimens on Individuals with Type 2 Diabetes during Ramadan Fasting in the DAR Global Surveys of 2020 and 2022
Effect of Different Insulin Regimens on Individuals with Type 2 Diabetes during Ramadan Fasting in the DAR Global Surveys of 2020 and 2022 Open
The DAR (Diabetes and Ramadan International Alliance) global surveys of 2020 and 2022 presented a unique opportunity to study the differences among various insulin treatment regimens during Ramadan fasting in individuals with diabetes to b…
View article: Erratum. 5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes: Standards of Care in Diabetes—2025. Diabetes Care 2025;48(Suppl. 1):S86–S127
Erratum. 5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes: Standards of Care in Diabetes—2025. Diabetes Care 2025;48(Suppl. 1):S86–S127 Open
In Table 5.4, “Elements for risk calculation and suggested risk score for people with diabetes who seek to fast during Ramadan,” of the article cited above, the risk score for type 2 diabetes was mistakenly given as 2; the correct risk sco…
View article: Noninvasive Assessment of the Severity of Liver Fibrosis in MASLD Patients with Long-Standing Type 2 Diabetes
Noninvasive Assessment of the Severity of Liver Fibrosis in MASLD Patients with Long-Standing Type 2 Diabetes Open
Background Type 2 diabetes mellitus (T2DM) and metabolic dysfunction–associated steatotic liver disease (MASLD), which have a reciprocal relationship compounded by obesity, are highly prevalent in the Middle East affecting morbidity, morta…
View article: Frequency of Cardiac Events in Patients with or without Diabetes Admitted to a Cardiac Unit of Dubai Hospital before, during, and after Ramadan
Frequency of Cardiac Events in Patients with or without Diabetes Admitted to a Cardiac Unit of Dubai Hospital before, during, and after Ramadan Open
Objective To understand the impact of Ramadan fasting on people with diabetes and cardiovascular diseases (CVDs). Many people with diabetes have a range of CVD conditions, such as coronary artery disease, heart failure, and/or diabetic car…
View article: Modern-Day Management of the Dysglycemic Continuum: An Expert Viewpoint from the Arabian Gulf
Modern-Day Management of the Dysglycemic Continuum: An Expert Viewpoint from the Arabian Gulf Open
Prediabetes is the first stage of a continuum that extends through the diagnosis of clinical type 2 diabetes towards long-standing diabetes with multiple comorbidities. The diagnosis of prediabetes provides an opportunity to interrupt the …
View article: Efficacy and Safety of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor Use during Ramadan Fasting: A Systematic Review
Efficacy and Safety of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor Use during Ramadan Fasting: A Systematic Review Open
Background Religious intermittent fasting for 30 days during Ramadan may increase the risk of dehydration, hypovolemia, and hypoglycemia. These events may also be encountered when using sodium-glucose cotransporter 2 inhibitors (SGLT2is). …
View article: Prevalence of Prediabetes among Adult Population of Dubai, the United Arab Emirates: Findings from Dubai Household Survey, 2019
Prevalence of Prediabetes among Adult Population of Dubai, the United Arab Emirates: Findings from Dubai Household Survey, 2019 Open
Introduction: The health and social burdens of diabetes mellitus (DM) and prediabetes are steadily increasing worldwide, reflecting the impact of industrial transitions; shifting to unhealthy, sedentary life patterns; and unhealthy food co…
View article: Aflibercept or ranibizumab for diabetic macular edema
Aflibercept or ranibizumab for diabetic macular edema Open
Background: Vascular endothelial growth factor (VEGF) is the primary substance involved in retinal barrier breach. VEGF overexpression may cause diabetic macular edema (DME). Laser photocoagulation of the macula is the standard treatment f…
View article: Acute Kidney Injury in Patients with Chronic Liver Disease: A Review
Acute Kidney Injury in Patients with Chronic Liver Disease: A Review Open
Introduction: Acute kidney injury (AKI) is a frequent complication of chronic liver disease (CLD) contributing to high morbidity and mortality worldwide. While liver transplantation (LT) has shown favorable outcomes, early identification a…
View article: Ramadan fasting among adults with type 2 diabetes in five geographically different regions of the world: The DAR 2020 global survey
Ramadan fasting among adults with type 2 diabetes in five geographically different regions of the world: The DAR 2020 global survey Open
Aims: The DAR 2020 survey summarised fasting practices and complications in people with type 2 diabetes (T2D) who fasted during Ramadan, and impact of pre-Ramadan diabetes education towards controlling the complications. Methods: Eight wee…
View article: Etiologies underlying subtypes of long-standing type 2 diabetes
Etiologies underlying subtypes of long-standing type 2 diabetes Open
Background Attempts to subtype, type 2 diabetes (T2D) have mostly focused on newly diagnosed European patients. In this study, our aim was to subtype T2D in a non-white Emirati ethnic population with long-standing disease, using unsupervis…
View article: Characteristics of non-fasting patients with diabetes type 2 in the DAR global surveys of 2020 and 2022
Characteristics of non-fasting patients with diabetes type 2 in the DAR global surveys of 2020 and 2022 Open
Introduction: The decision to fast or not is quite complex. Personal, medical and religious matters may influence it for individuals with diabetes. However, a diagnosis of diabetes does not constitute an automatic exemption from Ramadan fa…